BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/25/2025 8:27:20 AM | Browse: 47 | Download: 262
 |
Received |
|
2025-08-01 07:50 |
|
Peer-Review Started |
|
2025-08-01 07:50 |
|
First Decision by Editorial Office Director |
|
2025-08-20 06:59 |
|
Return for Revision |
|
2025-08-20 06:59 |
|
Revised |
|
2025-09-12 05:28 |
|
Publication Fee Transferred |
|
2025-09-15 11:02 |
|
Second Decision by Editor |
|
2025-10-17 02:37 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-17 06:19 |
|
Articles in Press |
|
2025-10-17 06:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-15 02:48 |
|
Publish the Manuscript Online |
|
2025-12-25 08:27 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Visual screening and efficacy evaluation of high-performance fluorescent probe DAF-FM in esophagitis cancer transformation
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wan-Hua Chen, Cheng-Feng Cai, Bing-Zhong Gao, Wen-Shan Hong, Ying-Zhi Xu and Wen-Jie Cai |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of Fujian Province |
No. 2023J011787 |
| Quanzhou Science and Technology Program Project |
No. 2025QZC02DW |
|
| Corresponding Author |
Wen-Jie Cai, Chief Physician, Department of Radiation Oncology, Quanzhou First Hospital Affiliated to Fujian Medical University, No. 248-252 East Street, Quanzhou 362002, Fujian Province, China. caiwj2001@126.com |
| Key Words |
DAF-FM; Fluorescent probe; Esophageal cancer transformation; Nitric oxide; Visual screening; Efficacy evaluation; Lysosomal targeting |
| Core Tip |
This study systematically evaluated the high-performance fluorescent probe DAF-FM for visual screening and efficacy assessment of esophagitis-to-cancer transformation. DAF-FM exhibited concentration-dependent and time-dependent fluorescence responses to nitric oxide (NO), targeted lysosomes specifically (Pearson coefficient = 0.82 ± 0.03), and had low cytotoxicity (82.3% ± 4.1% cell viability at 50 μM). In Sprague-Dawley rat esophagitis cancer models, DAF-FM monitored NO changes dynamically, with results positively correlated to tumor volume (R² = 0.87) post 5-fluorouracil/radiotherapy. Clinically, it outperformed endoscopic biopsy (sensitivity: 92.5% vs 78.3%) and shortened detection time (30 minutes vs 48 hours). Mechanistically, NO regulates carcinogenesis via the nuclear factor-kappa B pathway, clarifying DAF-FM’s molecular logic in reflecting transformation stages. |
| Publish Date |
2025-12-25 08:27 |
| Citation |
Chen WH, Cai CF, Gao BZ, Hong WS, Xu YZ, Cai WJ. Visual screening and efficacy evaluation of high-performance fluorescent probe DAF-FM in esophagitis cancer transformation. World J Gastrointest Surg 2025; 17(12): 110617 |
| URL |
https://www.wjgnet.com/1948-9366/full/v17/i12/110617.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v17.i12.110617 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
